|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00460 SIHUAN PHARM
Nominal 
0.710 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 949,697 | -10.041% | 1,055,705 | 1,464,197 | 1,907,219 | 1,054,537 |
| Cost of Sales | (341,181) | 10.783% | (307,972) | (460,508) | (440,096) | (268,480) |
| Gross Profit | 608,516 | -18.619% | 747,733 | 1,003,689 | 1,467,123 | 786,057 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | (98,097) | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 4,144 | -- | (45,672) | (47,733) | (50,699) | (11,429) | |
| Profit / (Loss) before Taxation | (19,212) | -41.877% | (33,054) | 56,042 | 819,483 | 302,120 | |
| Taxation | (48,746) | -43.243% | (85,886) | (151,943) | (225,265) | (133,427) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | (24,436) | |
| Non-controlling Interests | 34,534 | -50.165% | 69,296 | 136,277 | 17,206 | 5,733 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (33,424) | -32.673% | (49,644) | 40,376 | 611,424 | 149,990 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 58,621 | 4.505% | 56,094 | 25,259 | (52,942) | (65,625) |
| Depreciation & Amortisation | -- | -- | 122,327 | 179,022 | -- | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -0.360 | -32.075% | -0.530 | 0.430 | 6.460 | 1.580 |
| DPS (cts) | 1.900 | -- | 0.000 | 3.300 | 0.000 | 13.700 |
| Dividend Payout Ratio (%) | -- | -- | -- | 767.442% | -- | 867.089% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.474 | -- | 0.472 | 0.778 | 1.041 | 0.911 |
| Remarks: | Real time quote last updated: 13/11/2024 16:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -33,424,000 |
| %Change | -32.673% |
| EPS / (LPS) | RMB -0.004 |
| NBV Per Share (¥) | RMB 0.474 |